Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jun;36(6):357-61.
doi: 10.1290/1071-2690(2000)036<0357:COFNEO>2.0.CO;2.

Characterization of four novel epithelial ovarian cancer cell lines

D M Provencher, H Lounis, L Champoux, M Tétrault, E N Manderson, J C Wang, P Eydoux, R Savoie, P N Tonin, A M Mes-Masson

Characterization of four novel epithelial ovarian cancer cell lines

D M Provencher et al. In Vitro Cell Dev Biol Anim. 2000 Jun.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Lab-on-Chip Platform for Culturing and Dynamic Evaluation of Cells Development.
    Podwin A, Lizanets D, Przystupski D, Kubicki W, Śniadek P, Kulbacka J, Wymysłowski A, Walczak R, Dziuban JA. Podwin A, et al. Micromachines (Basel). 2020 Feb 14;11(2):196. doi: 10.3390/mi11020196. Micromachines (Basel). 2020. PMID: 32074950 Free PMC article.
  • Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
    Harrington BS, He Y, Davies CM, Wallace SJ, Adams MN, Beaven EA, Roche DK, Kennedy C, Chetty NP, Crandon AJ, Flatley C, Oliveira NB, Shannon CM, deFazio A, Tinker AV, Gilks CB, Gabrielli B, Brennan DJ, Coward JI, Armes JE, Perrin LC, Hooper JD. Harrington BS, et al. Br J Cancer. 2016 Feb 16;114(4):417-26. doi: 10.1038/bjc.2015.471. Epub 2016 Feb 4. Br J Cancer. 2016. PMID: 26882065 Free PMC article.
  • ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG. Wiegand KC, et al. N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8. N Engl J Med. 2010. PMID: 20942669 Free PMC article.
  • Interleukin-6 as a therapeutic target in human ovarian cancer.
    Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, Thompson R, Schioppa T, Nemeth J, Vermeulen J, Singh N, Avril N, Cummings J, Rexhepaj E, Jirström K, Gallagher WM, Brennan DJ, McNeish IA, Balkwill FR. Coward J, et al. Clin Cancer Res. 2011 Sep 15;17(18):6083-96. doi: 10.1158/1078-0432.CCR-11-0945. Epub 2011 Jul 27. Clin Cancer Res. 2011. PMID: 21795409 Free PMC article. Clinical Trial.
  • Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy.
    Skorupa A, Klimek M, Ciszek M, Pakuło S, Cichoń T, Cichoń B, Boguszewicz Ł, Witek A, Sokół M. Skorupa A, et al. Int J Mol Sci. 2024 Oct 10;25(20):10903. doi: 10.3390/ijms252010903. Int J Mol Sci. 2024. PMID: 39456684 Free PMC article.
See all "Cited by" articles

References

    1. Gynecol Oncol. 1995 Jan;56(1):39-44 - PubMed
    1. Gynecol Oncol. 1996 Jul;62(1):82-8 - PubMed
    1. Differentiation. 1993 May;53(1):45-50 - PubMed
    1. Gynecol Oncol. 1993 Jul;50(1):78-83 - PubMed
    1. In Vitro Cell Dev Biol. 1990 May;26(5):447-54 - PubMed

Publication types

LinkOut - more resources